We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ARVN market cap is 1.71B. The company's latest EPS is USD -5.3454 and P/E is -4.67.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.6M | -43.1M | 25.3M | 76.5M | 102.4M |
| Operating Income | -74M | -165.3M | -83.3M | -48.5M | -60.2M |
| Net Income | -64M | -154.8M | -69.4M | -35.2M | -49.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.98M | 21.8M | 46.7M | 131.4M | 78.5M |
| Operating Income | -76.2M | -124.86M | -195.3M | -273.8M | -404M |
| Net Income | -70.29M | -119.33M | -191M | -282.5M | -367.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.06B | 1.3B | 1.21B | 1.28B | 1.17B |
| Total Liabilities | 601.1M | 644.6M | 602.9M | 679.4M | 581.1M |
| Total Equity | 457.2M | 660M | 609.7M | 600.2M | 586M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 301.64M | 717.37M | 1.58B | 1.27B | 1.3B |
| Total Liabilities | 74.96M | 75.11M | 799.9M | 703.9M | 644.6M |
| Total Equity | 226.69M | 642.26M | 781.7M | 564.9M | 660M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -264.7M | -347.8M | -97.7M | -47.2M | -175.2M |
| Investing | 257.2M | 203.5M | -127.8M | -114.7M | -64.2M |
| Financing | 39.9M | 374.7M | 1.6M | 5M | 7.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.63M | -89.76M | 559.4M | -273.5M | -347.8M |
| Investing | -93.1M | 164.25M | -1.31B | 242.8M | 203.5M |
| Financing | 139.74M | 504.67M | 278.6M | 4.7M | 374.7M |
| Market Cap | 1.71B |
| Price to Earnings Ratio | -4.67 |
| Price to Sales Ratio | 21.84 |
| Price to Cash Ratio | 5.5 |
| Price to Book Ratio | 2.6 |
| Dividend Yield | - |
| Shares Outstanding | 68.71M |
| Average Volume (1 week) | 768.71k |
| Average Volume (1 Month) | 635.52k |
| 52 Week Change | 25.99% |
| 52 Week High | 53.08 |
| 52 Week Low | 19.31 |
| Spread (Intraday) | 0.41 (1.62%) |
| Company Name | Arvinas Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.arvinas.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
